Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments. It also offers medical, property and vehicle rental, consultancy, and franchise contracting services. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in São Paulo, Brazil.
Frequently asked questions
What sector does Diagnósticos da América S.A (DASA3) operate in?
Diagnósticos da América S.A belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Diagnósticos da América S.A (DASA3) current stock price?
As of the latest data, Diagnósticos da América S.A stock price is R$2.55, with a previous close of R$2.54. Diagnósticos da América S.A gained R$0.01 in the last trading session, representing a 0.39% increase.
What is Diagnósticos da América S.A (DASA3) current market capitalization?
Diagnósticos da América S.A market cap is approximately 3.19 billion.
What is Diagnósticos da América S.A (DASA3) Earnings Per Share (EPS)?
The trailing EPS is -R$0.82, and the forward EPS is R$0.23.
What is Diagnósticos da América S.A (DASA3) EBITDA?
Diagnósticos da América S.A EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 576.17 million.
Does Diagnósticos da América S.A (DASA3) pay dividends?
No. Diagnósticos da América S.A does not pay a dividend.
What is Diagnósticos da América S.A (DASA3) beta (volatility) score?
Diagnósticos da América S.A has a beta of 0.323, indicating lower volatility than the overall market.
